ARYVX
Price
$15.46
Change
+$0.27 (+1.78%)
Updated
Jul 24 closing price
Net Assets
834.72M
MGLJX
Price
$18.14
Change
+$0.32 (+1.80%)
Updated
Jul 24 closing price
Net Assets
2.24B
Interact to see
Advertisement

ARYVX vs MGLJX

ARYVX vs MGLJX Comparison Chart in %
View a ticker or compare two or three
VS
ARYVX vs. MGLJX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYVX is a Buy and MGLJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLJX has more cash in the bank: 2.24B vs. ARYVX (835M). ARYVX pays higher dividends than MGLJX: ARYVX (2.73) vs MGLJX (2.00). ARYVX was incepted earlier than MGLJX: ARYVX (15 years) vs MGLJX (12 years). MGLJX (1.94) is less costly to investors than ARYVX (1.11). ARYVX is a more actively managed with annual turnover of: 137.00 vs. MGLJX (35.00). MGLJX has a lower initial minimum investment than ARYVX: MGLJX (0) vs ARYVX (2500). ARYVX annual gain was more profitable for investors over the last year : 18.68 vs. MGLJX (12.83). ARYVX return over 5 years is better than : 12.37 vs. MGLJX (-9.21).
ARYVXMGLJXARYVX / MGLJX
Total Expense Ratio1.111.9358%
Annual Report Gross Expense Ratio1.111.9457%
Fund Existence15 years12 years-
Gain YTD15.63213.588115%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets835M2.24B37%
Annual Yield % from dividends2.732.00137%
Returns for 1 year18.6812.83146%
Returns for 3 years39.0316.60235%
Returns for 5 years12.37-9.21-134%
Returns for 10 years63.2319.37326%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GWGIX22.510.03
+0.13%
AMG GW&K Small Mid Cap Core I
WEUSX15.37-0.02
-0.13%
SEI World Equity Ex-US A (SIIT)
FBTTX41.62-0.08
-0.19%
Fidelity Advisor Biotechnology M
FSEBX16.96-0.04
-0.24%
Fidelity Advisor Sustainable U.S. Eq
PASIX10.49-0.03
-0.29%
PACE Alternative Strategies A